Clinical trial · Observational
Study on the Long-Term Risk of Recurrence of Anoperineal Fistula in Crohn's Disease
Study on the Long-Term Risk of Recurrence of Anoperineal Fistula After Treatment With Anti-tumor Necrosis Factor (TNF) and Seton Drainage in Crohn's Disease : LT-SAFCD
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research aims to evaluate the long-term recurrence risk of perianal fistulas in Crohn's disease patients who have undergone treatment with anti-TNF therapy and seton drainage.The research seeks to identify factors influencing recurrence and assess the long term effectiveness of these treatments in preventing fistula recurrence. This study will provide insights that could enhance treatment strategies and improve patient outcomes.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Crohn Disease | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| anti-TNF therapy and seton drainage | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Crohn's patients
- interventionNames
- Other: anti-TNF therapy and seton drainage
Primary outcomes (1)
- measure
- Long-term recurrence-free survival rate of perianal fistulas
- timeFrame
- through study completion, an average of 2 years
- description
- To evaluate the long-term recurrence-free survival rate of perianal fistulas after combined treatment with anti-TNF alpha and seton drainage
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Confirmed diagnosis of Crohn's disease * drainage of an anal fistula with seton combined with the initiation of anti-TNF alpha treatment * Patient who was treated in the digestive center of the Toulouse University Hospital for drainage of an anal fistula between January 1, 2000 and December 31, 2010 Exclusion Criteria: Patient followed less than 6 months after seton drainage
References
Publications (0)
Data not yet available